How to Lose Weight During Perimenopause: Why It Gets Harder and What Actually Helps

Understand how hormonal changes affect weight during perimenopause and explore practical strategies involving nutrition, exercise, sleep, and physician-guided medical support when appropriate.

Majesta HealthReviewed by Ksenia Petrushkina, PA-C
Published Updated Reviewed 18 min read

Understand how hormonal changes affect weight during perimenopause and explore practical strategies involving nutrition, exercise, sleep, and physician-guided medical support when appropriate.

You are eating the same foods and exercising like you always have, yet the scale keeps climbing. The strategies that worked for two decades suddenly seem useless. If this sounds familiar, you are not alone. Weight gain and changes in fat distribution are common during the menopausal transition, and the frustration is real, but so is the science explaining why your body changed.

This article breaks down the hormonal and metabolic shifts behind perimenopausal weight gain, why traditional calorie-cutting often backfires, and what evidence-based strategies actually work. For women who qualify, GLP-1 weight management options through telehealth platforms offer a medical approach to weight management.

Majesta Health currently offers a waitlist for its physician-guided treatment plans, with enrollment subject to opening, state availability, and physician approval. Understanding the biology is the first step toward finding solutions that match your changing body.

Key Takeaways

  • Weight gain during midlife reflects a combination of aging, lifestyle factors, and hormonal changes, while declining estrogen contributes to abdominal fat redistribution
  • Age-related muscle loss, changes in physical activity, and hormonal shifts can affect energy expenditure and make weight management more challenging
  • Strength training 2-3 times weekly helps preserve muscle mass and maintain metabolic health
  • Protein intake of 20-25 grams per meal supports muscle preservation and satiety during hormonal transitions
  • GLP-1 medications may support weight management for eligible women alongside lifestyle changes, following evaluation and approval by a licensed physician
  • Sleep disruption is common during perimenopause and may make weight management more challenging
  • Medical weight loss options require evaluation by a licensed physician to determine if treatment is appropriate

Understanding Perimenopause Weight Gain: Why It Gets Harder

The menopausal transition typically begins in your 40s and lasts several years. During this time, your body undergoes fundamental changes that directly affect how you store and burn energy.

A 2019 SWAN study found that the rate of fat gain doubled at the start of the menopausal transition, while lean mass began declining. However, overall body weight continued increasing at a steady pace rather than accelerating during the transition. These findings help explain why your body shape can change even when the scale shows relatively little difference. The findings represent group averages, and individual changes vary.

What changes during the menopausal transition?

Long-term studies have identified several changes in body composition, fat distribution, and energy expenditure. The table below summarizes their findings.

MeasureWhat studies foundStudy
Body weightContinued rising without an acceleration at the start of the transitionSWAN, 2019
Body fatRate of fat gain doubled at the beginning of the transitionSWAN, 2019
Lean massBegan declining during the transitionSWAN, 2019
Abdominal fatVisceral fat increased by 22%, despite relatively little change in overall weightDehghan et al., 2021
Resting energy expenditureRemained relatively stable on average in MONET, while sleeping energy expenditure declined somewhat more among women reaching menopause in LovejoyMONET, 2013; Lovejoy, 2008
Total daily energy expenditureDeclined in MONET, largely alongside reduced physical activityMONET, 2013

Sources: *SWAN,* *Dehghan et al.,* *MONET, and* *Lovejoy. Findings describe study populations and should not be interpreted as predictions for individuals.*

The Hormonal Shift: Estrogen's Role in Fat Storage

Before perimenopause, estrogen performs several metabolic functions:

  • Regulates insulin production and glucose metabolism
  • Maintains muscle mass through receptor signaling
  • Directs fat storage to hips and thighs (subcutaneous fat)
  • Helps regulate hunger signals

As estrogen levels fluctuate and decline, these protective mechanisms weaken. The result is a cascade effect that makes weight management increasingly difficult.

Metabolic Slowdown: Why Your Body Changes How It Burns Calories

Energy expenditure can change during midlife as muscle mass, physical activity, and body composition shift. These changes vary between individuals, and not every woman experiences the same metabolic slowdown. Losing muscle and becoming less physically active may also reduce daily calorie needs.

Studies have reported different findings about resting metabolism.

  • The MONET study found that resting energy expenditure remained stable on average among women who became postmenopausal, while total daily energy expenditure declined mainly because of reduced physical activity.
  • In contrast, a 2008 longitudinal study found that sleeping energy expenditure declined somewhat more in women who reached menopause than in those who remained premenopausal.

Together, these findings suggest that changes in metabolism are not uniform and that physical activity remains an important factor.

Dietary Strategies for Weight Loss During Perimenopause

What you eat matters more than ever during perimenopause, but extreme calorie restriction often backfires by contributing to muscle loss and making weight management harder to sustain.

Prioritizing Protein: Building Muscle and Satiety

Adequate protein intake is important for preserving muscle mass during midlife. Research supports consuming:

  • 1-1.2 grams of protein per kilogram of body weight daily
  • 20-25 grams of protein per meal to support muscle protein synthesis
  • For a 150-pound woman: approximately 68-82 grams of protein daily

Individual protein needs vary based on age, activity level, health conditions, and other factors.

Good protein sources include lean meats, fish, eggs, Greek yogurt, legumes, tofu, and tempeh.

Learn more about GLP-1 protein needs.

Focusing on Whole Foods: What to Eat and Avoid

A perimenopause-friendly eating pattern emphasizes:

  • Fiber-rich foods: Aim for approximately 25 grams daily, adjusting intake according to age and individual nutritional needs
  • Healthy fats: Omega-3 fatty acids from fish, nuts, and seeds
  • Phytoestrogens: Soy, flaxseeds, and legumes, although evidence for menopausal symptom relief remains mixed
  • Limit: Processed foods, refined carbohydrates, and added sugars

The goal is nutrient density rather than severe restriction. Creating a moderate, sustainable calorie deficit is generally more manageable than aggressive cutting that may contribute to muscle loss and metabolic adaptation.

Exercise and Lifestyle Adjustments for Perimenopause Weight Management

Exercise during perimenopause requires a strategic shift in priorities. Cardio alone is not enough.

Building Muscle: The Key to Boosting a Slow Metabolism

Strength training is an important part of weight management during perimenopause. Research supports resistance exercise for preserving muscle mass and improving physical strength during weight loss.

Practical implementation:

  • Frequency: 2-3 sessions per week
  • Focus: Compound movements (squats, lunges, deadlifts, push-ups, rows)
  • Progressive overload: Gradually increase weight or resistance
  • Recovery: Allow rest days between sessions

Weight-bearing and resistance exercises also help preserve bone density, which becomes increasingly important during this life stage.

Beyond the Gym: Stress, Sleep, and Hydration for Weight Loss

Lifestyle factors significantly impact perimenopausal weight:

Sleep: Sleep disruption is common during perimenopause, partly because of symptoms such as hot flashes and night sweats. Poor sleep can increase hunger, affect appetite regulation, and make weight management more challenging. Aim for 7-9 hours nightly and keep your bedroom between 60-67°F if comfortable.

Stress: Chronic stress can affect appetite, sleep, and behaviors that influence weight management. Evidence-based approaches include meditation, deep breathing, yoga, and cognitive behavioral therapy.

Physical activity: Beyond formal exercise, increase daily movement through walking and other activities. A goal of 6,000 or more steps can be a useful starting point, depending on your current activity level.

Perimenopause weight-management plan at a glance

A consistent routine involving strength training, nutrition, sleep, and regular movement can support weight management during perimenopause. The following table brings together the practical recommendations discussed in this article.

HabitGeneral target or approachWhy it matters
Strength training2-3 sessions weekly, with appropriate recoveryHelps preserve muscle and maintain strength
ProteinIndividualized daily intake; approximately 20-25 g per meal may be appropriateSupports muscle preservation and satiety
Daily movementWalk and reduce prolonged sitting; increase activity graduallySupports daily energy expenditure
SleepAim for 7-9 hours nightlySupports appetite regulation and recovery
Stress managementPractice sustainable relaxation or coping techniquesMay improve sleep and healthy routines
Fiber-rich foodsApproximately 25 g daily, adjusted for age and individual needsSupports digestive health and fullness
Calorie intakeFavor a moderate, sustainable deficit when weight loss is appropriateHelps avoid unnecessarily restrictive eating patterns

These are general approaches, not individualized medical targets. Your clinician or registered dietitian can help adjust them to your health, activity level, and nutritional needs.

The Role of Metabolism in Perimenopausal Weight Loss

Understanding your changing metabolism helps explain why old strategies fail and what new approaches are needed.

Decoding Your Metabolism: How Hormones Impact Energy Burn

Your basal metabolic rate (BMR), the calories your body burns at rest, depends heavily on muscle mass and hormonal function. During perimenopause, changes in estrogen levels and body composition can affect metabolic health through several pathways:

  • Muscle loss: Less metabolically active tissue means fewer calories burned at rest
  • Insulin resistance: Cells become less responsive to insulin, which can impair blood sugar regulation and contribute to metabolic changes
  • Thyroid function: Thyroid disorders can also affect metabolism and may require separate medical evaluation

Research on the menopausal transition has documented changes in energy expenditure, body composition, and abdominal fat distribution.

After weight loss, the body may burn somewhat fewer calories than predicted, though better-designed studies find this effect is small and tends to fade once weight stabilizes.

Strategies to Naturally Boost a Slow Metabolism

Rather than fighting your biology, work with it:

  • Preserve muscle: Make strength training a regular part of your routine
  • Eat adequate protein: Higher thermic effect means more calories burned during digestion
  • Stay active throughout the day: Non-exercise activity thermogenesis (NEAT) adds up
  • Get quality sleep: Poor sleep can affect metabolic function
  • Manage stress: Stress management may support healthier sleep, eating, and activity habits

Research published in 2025 supports resistance exercise for preserving fat-free mass during dietary weight loss.

Addressing Menopause Belly Fat: Targeted Strategies

One of the most frustrating changes during perimenopause is the shift in where your body stores fat.

Why Belly Fat Increases During Perimenopause

Before perimenopause, estrogen directs fat storage to hips and thighs (subcutaneous fat). As estrogen declines, fat redistributes to the abdomen. A 2021 prospective study found that visceral fat increased by 22% across the menopausal transition, even though participants experienced relatively little change in overall body weight.

This matters beyond aesthetics. Visceral fat has been linked to inflammation and insulin resistance, which can contribute to metabolic health risks.

A 2021 study of adipose tissue changes also identified associations between menopause, abdominal fat accumulation, tissue inflammation, and reduced insulin sensitivity.

Beyond Crunches: Holistic Approaches to Reduce Abdominal Fat

You cannot spot-reduce belly fat through targeted exercises alone. Effective strategies address the underlying drivers:

  • Manage stress: Stress-reduction strategies may support healthier eating, sleep, and weight-management habits
  • Improve insulin sensitivity: Strength training and dietary changes help
  • Support gut health: Fiber intake and probiotic-rich foods may help
  • Address sleep issues: Poor sleep has been linked to more abdominal fat
  • Consider medical options: If lifestyle changes alone are not enough, a licensed physician can tell you whether prescription weight-loss medication is appropriate for you

Does Hormone Replacement Therapy (HRT) Help With Weight Loss?

Hormone replacement therapy (HRT), also called menopausal hormone therapy, is not a weight-loss treatment and should not be prescribed solely for weight management. However, it can help manage certain menopause symptoms that interfere with sleep and daily routines.

According to the 2022 position statement of The North American Menopause Society, hormone therapy is the most effective treatment for hot flashes and night sweats and has also been shown to prevent bone loss. Relieving these symptoms may make it easier to maintain consistent sleep, nutrition, and exercise habits.

Some research suggests that hormone therapy may influence body fat distribution, but this does not establish it as an effective treatment for weight loss or guarantee a reduction in abdominal fat. Whether hormone therapy is appropriate depends on your symptoms, age, medical history, contraindications, and individual risks. A gynecologist or menopause clinician can help evaluate these factors.

Hormone therapy and GLP-1 medications serve different purposes. Majesta Health does not offer menopause hormone therapy.

Medical Weight Loss Treatments for Perimenopause

When lifestyle changes alone are not producing results, medical interventions may offer additional support for eligible adults.

When to Consider Medical Support for Perimenopausal Weight Loss

Prescription weight-loss medication may be considered for adults who meet established clinical criteria:

  • BMI of 30 or higher
  • BMI of 27 or higher with a weight-related health condition, such as hypertension or prediabetes

Additional concerns that may warrant a medical evaluation include persistent hunger, insulin resistance, or increased abdominal fat despite lifestyle changes. These concerns alone do not establish eligibility for medication.

These BMI-based criteria align with the National Institutes of Health's guidance on prescription medications for overweight and obesity.

A licensed physician must evaluate your medical history, health conditions, and individual needs to determine whether treatment is appropriate. Meeting BMI criteria alone does not guarantee treatment or a prescription.

Understanding GLP-1 Therapies: Semaglutide and Tirzepatide

GLP-1-based medications act on hormone receptors involved in appetite and blood sugar regulation. Semaglutide activates the GLP-1 receptor, while tirzepatide activates both GLP-1 and GIP receptors. These medications can help by:

  • Reducing appetite and food cravings
  • Slowing stomach emptying to increase feelings of fullness

Learn more about GLP-1 medications and how they work. For more on GLP-1 medicines and menopause, see Semaglutide for Menopause Weight Gain.

Although these medications have been studied for weight management in broader adult populations, evidence specifically involving women in perimenopause and early postmenopause remains limited. A 2026 clinical review also found that the effectiveness, safety, and potential interactions of GLP-1 medications when combined with menopausal hormone therapy require further research. These limitations reinforce the importance of individualized physician evaluation.

Important consideration: GLP-1 medications can result in muscle loss alongside fat loss. Combining treatment with strength training and adequate protein intake can help support muscle preservation.

Compounded medications are not FDA-approved as final products and are not generic versions of, equivalent to, or interchangeable with any FDA-approved medication.

The FDA cautions that compounded GLP-1 medications do not undergo the agency's premarket review for safety, effectiveness, and quality. Medication selection requires evaluation and approval by a licensed physician, and individual results may vary.

Safety considerations: A compounded medicine has no FDA-approved prescribing label of its own. FDA prescribing information for semaglutide and tirzepatide products carries a boxed warning on thyroid C-cell tumors, based on rodent findings, and lists a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 as contraindications. It also lists pancreatitis and gallbladder problems among the serious risks, and nausea, vomiting, diarrhea, and constipation among the common side effects. These warnings come from FDA-approved products and do not establish identical safety profiles for compounded preparations. A licensed physician should review your medical history and these risks before considering treatment.

Pregnancy and contraception considerations: Pregnancy remains possible during perimenopause, even when menstrual cycles become irregular. FDA-approved semaglutide and tirzepatide products carry warnings about potential fetal harm, and the Zepbound prescribing information also warns that tirzepatide may reduce the effectiveness of oral hormonal contraceptives. If you are pregnant, planning pregnancy, breastfeeding, or using hormonal contraception, discuss these factors with your prescribing physician before considering treatment. The physician should evaluate the applicable medication-specific risks and precautions.

The Benefits of Doctor-Guided GLP-1 Treatment for Women

Medical weight loss requires proper physician oversight rather than a one-size-fits-all approach.

Physician-Led Care: Why It Matters

A physician-guided program provides:

  • Individual assessment: Evaluation of your medical history, current health, and weight loss goals
  • Appropriate medication selection: Determining if semaglutide or tirzepatide fits your situation
  • Dose decisions: Your physician decides the medicine and the dose
  • Side effect support: Guidance for managing nausea, constipation, or other common effects
  • Ongoing monitoring: Regular check-ins to adjust treatment as needed

Physician oversight supports individualized treatment decisions, appropriate monitoring, and ongoing evaluation of potential benefits and risks.

Transparency and Safety in Telehealth GLP-1 Providers

Not all telehealth weight loss platforms operate with the same standards. Knowing what to look for protects your health and investment.

What to Look for: Ensuring a Safe and Compliant Telehealth Experience

When evaluating telehealth providers, verify:

  • LegitScript certification: Third-party verification of legitimate healthcare merchant operations, not an endorsement of medication safety or effectiveness
  • Named physicians: Providers should identify their licensed physicians with verifiable credentials
  • Named pharmacy partners: Know where your medication comes from and which licensed pharmacy dispenses your prescription
  • Clear FDA disclaimers: Transparent acknowledgment that compounded medications are not FDA-approved as final products
  • Transparent pricing: All-inclusive costs without hidden fees or surprise charges
  • HIPAA-compliant practices: Proper handling of your health information

The FDA's guidance on compounding explains important regulatory differences between compounded medications and FDA-approved drugs.

A provider unwilling to disclose these details warrants caution.

Perimenopause Weight Gain Supplements: What Works and What Doesn't

The supplement market targets perimenopausal women aggressively, but evidence for most products remains limited.

Separating Fact from Fiction: Evaluating Supplement Claims

Supplements with some supporting evidence for specific health needs:

  • Magnesium: Supports normal muscle and nerve function, with limited evidence suggesting supplementation may improve sleep in some individuals
  • Vitamin D: Important for bone health; peri- and postmenopausal women are vulnerable to low vitamin D
  • Omega-3 fatty acids: Support normal cardiovascular function, although evidence for meaningful weight loss remains limited
  • Probiotics: May support certain aspects of gut health, but evidence for meaningful weight loss remains inconsistent

Supplements with limited evidence for weight loss:

  • Most "menopause belly" supplements lack rigorous clinical support
  • Herbal weight loss products often carry more risk than benefit
  • "Metabolism boosters" rarely produce meaningful results

Before starting any supplement, discuss options with your healthcare provider. Supplements cannot replace the fundamentals of nutrition, exercise, and sleep.

Why Majesta Health Is Worth Considering for Doctor-Guided GLP-1 Treatment

For women considering doctor-guided medical weight loss, Majesta Health is a LegitScript-certified, women-centered telehealth platform with two planned injectable treatment options. As of November 16, 2026, enrollment had not yet opened. The early-access waitlist is available, but treatment can begin only after enrollment opens and an independent physician licensed in the patient's state determines that treatment is appropriate.

Majesta Health connects patients with independent, U.S.-licensed physicians who evaluate medical eligibility and make all prescribing decisions. Majesta does not itself prescribe or dispense medications.

When treatment is approved and prescribed, medications are dispensed by state-licensed compounding pharmacies.

Women-Centered Care with Full Transparency

Majesta Health differentiates itself through:

  • LegitScript certification: Healthcare Merchant Certification obtained on August 26, 2026
  • Named physicians: A network of independent, U.S.-licensed physicians whose credentials can be verified through publicly listed physician information
  • Named pharmacy partners: Belmar Pharma Solutions and Strive Pharmacy, as confirmed by Majesta on November 16, 2026. The dispensing pharmacy for an individual prescription depends on the applicable arrangements
  • Transparent pricing: Plan pricing includes physician care, prescribed medication, and shipping, without separate membership or enrollment fees

The platform has two planned injectable treatment options, with the following plan details confirmed by the company on November 16, 2026:

  • Essential Plan (compounded Semaglutide/Glycine/B12 Injection): $159 for the first month and $289/month thereafter. Includes a $20 physician consultation within the plan price, monthly physician check-ins, care-team messaging, prescribed medication when approved, and shipping.
  • Performance Plan (compounded Tirzepatide/Glycine/B12 Injection): $269 for the first month and $399/month thereafter. Includes the same care and support structure, with tirzepatide acting on both GIP and GLP-1 receptors. Treatment appropriateness is determined by the prescribing physician.
  • Express Plan (compounded Tirzepatide LPT® Chewable Tablets): Proposed pricing of $249 for the first approved 30-day care cycle and $339 per approved 30-day care cycle thereafter. The plan is not yet available for enrollment. Treatment requires physician review and approval, with medication and shipping included when prescribed.

These prices reflect Majesta's November 16, 2026 company-confirmed update. Publicly displayed offers and pricing information may differ, so readers should check the current plan pricing and applicable enrollment terms.

Both planned injectable plans include 2-day shipping after pharmacy preparation, with preparation time handled separately. Shipping timelines do not guarantee a delivery date. Patients can cancel anytime without a cancellation fee by emailing support@majestahealth.com.

Majesta has also confirmed a planned Express option featuring compounded Tirzepatide LPT® Chewable Tablets for oral use. This option is not available for purchase, and its final pricing, availability, and terms remain subject to confirmation before enrollment.

Ksenia Petrushkina, PA-C, co-founder of Majesta Health, is a certified physician assistant with clinical experience in medical weight management, GLP-1 therapies, metabolic health, and women's hormonal health, including perimenopause, menopause, and thyroid disorders. Majesta focuses on helping women feel informed, respected, and heard during their weight management journey.

Compounded medications are not FDA-approved as final products and are not generic versions of, equivalent to, or interchangeable with any FDA-approved medication.

Compounded GLP-1 medications may cause side effects, including nausea, vomiting, diarrhea, and constipation. Serious risks and contraindications also require consideration, including pancreatitis, gallbladder problems, and certain thyroid cancer histories. A licensed physician should review these risks, the patient's medical history, and treatment alternatives before prescribing. The FDA highlights safety concerns associated with unapproved GLP-1 drugs.

Struggling with weight loss during perimenopause? Majesta Health offers a way to explore physician-guided treatment options when enrollment opens. An independent, U.S.-licensed physician will review your health history and determine whether treatment is appropriate.

Start your assessment to join early access. The assessment takes approximately two minutes, requires no payment or medication order, and does not guarantee a prescription.

Nothing is charged unless a physician approves treatment.

Before you change anything

Talk with your clinician before starting a new diet, exercise plan or supplement, especially if you take other medicines or have a health condition. This article does not suggest starting, stopping or changing any medicine.

When to get help right away

Call 911 for severe abdominal pain, chest pain, trouble breathing, fainting or signs of a severe allergic reaction. Contact your clinician promptly about heavy or unusual bleeding, or symptoms that disrupt daily life.

This article is for informational purposes only and does not constitute medical advice, diagnosis or treatment. It does not recommend starting, stopping or changing any medicine.

Sources checked November 17, 2026.

Frequently Asked Questions

What is perimenopause and how does it affect weight?

Perimenopause is the transition period before menopause when estrogen levels fluctuate and eventually decline. This hormonal shift affects weight through multiple mechanisms, including changes in body composition, insulin sensitivity, and fat distribution toward the abdomen. Most women begin this transition in their 40s, and perimenopause lasts around four years on average, although the duration varies considerably.

Can GLP-1 medications help with perimenopausal weight gain?

GLP-1 medications may support weight management in eligible adults, including women experiencing perimenopause. Standard eligibility criteria for prescription weight management medications commonly include a BMI of 30 or higher, or 27 or higher with weight-related health conditions. These medications can help regulate appetite and food intake, but they do not specifically treat the hormonal changes of perimenopause. Treatment requires physician evaluation to determine appropriateness, and individual results vary.

How are compounded GLP-1 medications regulated?

Compounded medications are prepared by appropriately licensed pharmacies for individual patients under applicable federal and state requirements. They are not FDA-approved as final products and are not generic versions of, equivalent to, or interchangeable with FDA-approved medications. Compounded GLP-1 medications may be considered when a licensed prescriber determines that a patient's individual medical needs warrant them and applicable compounding requirements are met. However, they have not undergone FDA review for safety, effectiveness, or quality as finished products. Patients should discuss potential risks, alternatives, and treatment appropriateness with their prescribing physician.

What lifestyle changes are most impactful for perimenopausal weight loss?

Strength training 2-3 times weekly is an important intervention, as it helps preserve muscle mass and supports metabolic health during the menopausal transition. Adequate protein intake, often around 20-25 grams per meal depending on individual needs, quality sleep (7-9 hours), stress management, and consistent daily movement provide the foundation. These changes matter more than aggressive calorie restriction.

How long does menopause weight gain last?

The perimenopausal transition lasts around four years on average, although it can be shorter or considerably longer. Weight changes during menopause vary by individual, with aging, hormonal shifts, lifestyle, and changes in body composition all playing a role. However, with appropriate interventions including strength training, nutrition optimization, and medical support when appropriate, weight can be managed throughout and after the transition. The timeline varies by individual.

Sources

  1. 1.Weight Management Module for Perimenopausal Women: A Practical Guide for Gynecologists (Journal of Mid-life Health, 2019), full text · PubMed Central, U.S. National Library of Medicine · accessed
  2. 2.Effects of the Menopausal Transition on Factors Related to Energy Balance: A MONET Group Study. I. Energy Expenditure (European Journal of Clinical Nutrition, 2013), full text · PubMed Central, U.S. National Library of Medicine · accessed
  3. 3.The Role of Dietary Protein and Vitamin D in Maintaining Musculoskeletal Health in Postmenopausal Women (Maturitas, 2014), abstract · PubMed, U.S. National Library of Medicine · accessed
  4. 4.Effect of Resistance Exercise on Body Composition, Muscle Strength and Cardiometabolic Health During Dietary Weight Loss in People Living With Overweight or Obesity (BMJ Open Sport & Exercise Medicine, 2025), abstract · PubMed, U.S. National Library of Medicine · accessed
  5. 5.Effects of Sleep Restriction on Metabolism-Related Parameters in Healthy Adults: A Comprehensive Review and Meta-Analysis of Randomized Controlled Trials (Sleep Medicine Reviews, 2019), abstract · PubMed, U.S. National Library of Medicine · accessed
  6. 6.Does Adaptive Thermogenesis Occur After Weight Loss in Adults? A Systematic Review (British Journal of Nutrition, 2022), abstract · PubMed, U.S. National Library of Medicine · accessed
  7. 7.A Prospective Study of the Relationships Between Change in Body Composition and Cardiovascular Risk Factors Across the Menopause (Menopause, 2021), abstract · PubMed, U.S. National Library of Medicine · accessed
  8. 8.Prescription Medications to Treat Overweight & Obesity (National Institutes of Health), guidance · National Institute of Diabetes and Digestive and Kidney Diseases, NIH · accessed
  9. 9.FDA's Concerns With Unapproved GLP-1 Drugs Used for Weight Loss (U.S. Food and Drug Administration), guidance · U.S. Food and Drug Administration · accessed
  10. 10.Compounding and the FDA: Questions and Answers (U.S. Food and Drug Administration), guidance · U.S. Food and Drug Administration · accessed
  11. 11.Changes in Body Composition and Weight During the Menopause Transition (JCI Insight, 2019), full text · PubMed Central, U.S. National Library of Medicine · accessed
  12. 12.Increased Visceral Fat and Decreased Energy Expenditure During the Menopausal Transition (International Journal of Obesity, 2008), full text · PubMed Central, U.S. National Library of Medicine · accessed
  13. 13.Hormone Therapy Position Statement (The North American Menopause Society, 2022), professional guidance · The North American Menopause Society · accessed
  14. 14.GLP-1 Receptor Agonists in Perimenopause and Early Postmenopause: Clinical Role, Cardiometabolic Benefits and Knowledge Gaps (Climacteric, 2026), review · PubMed, U.S. National Library of Medicine · accessed
  15. 15.Zepbound Prescribing Information (DailyMed, U.S. National Library of Medicine), FDA-approved product labeling · DailyMed, U.S. National Library of Medicine · accessed
  16. 16.Majesta Health Pricing (Majesta Health), official plan and pricing information · Majesta Health · accessed
  17. 17.About Majesta Health (Majesta Health), official company and physician-guided care information · Majesta Health · accessed

Ready to Join Early Access?

Join the early access list and we will email you when enrollment opens.

Start Your Assessment